REFERENCES
- Widemann B C, Balis F M, Kempf-Bielack B, et al. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Cancer. 2004; 100: 2222–2232
- Rosen G, Caparros B, Huvos A G. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982; 49: 1221–1230
- Flombaum C D, Meyers P A. High-dose leucovorin as sole therapy for methotrexate toxicity. J Clin Oncol. 1999; 17: 1589–1594
- Frappaz D, Bouffett E, Cochat P, et al. Hemoperfusion on charcoal and hemodialysis in acute methotrexate intoxication. Presse Med 1988; 17: 1209–1213
- Relling M V, Stapleton F B, Ochs J, et al. Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusion. Cancer 1988; 62: 884–888
- Molina R, Fabian C, Cowley B, Jr. Use of charcoal hemoperfusion with sequential hemodialysis to reduce serum methotrexate levels in a patient with acute renal insuffiency. Am J Med 1987; 82: 350–352
- Ahmad S, Shen F H, Bleyer W A. Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis. Arch Intern Med 1978; 138: 1146–1147
- Hande K R, Balow J E, Drake J C, Rosenberg S A, Chabner B A. Methotrexate and hemodialysis. Ann Intern Med 1977; 87: 495–496
- Bouffet E, Frappaz D, Laville M, et al. Charcoal haemoperfusion and methotrexate toxicity. Lancet 1986; 1(8496)1497.
- Howell S B, Blair H E, Uren J, et al. Hemodialysis and enzymatic cleavage of methotrexate in man. Eur J Cancer 1978; 14: 787–792
- Giardino R, Fini M, Giavaresi, et al. Comparison of hemodialysis versus hemoperfusion in the clearance of high-dose methotrexate in pigs. Artif Organs 1995; 19: 362–365
- Thierry F X, Vernier I, Dueymes J M, et al. Acute renal failure after high-dose methotrexate therapy. Nephron 1989; 51: 416–417
- Cecyn K Z, Lee J, Oguro T, Petrilli A S, Bordin J O. Use of plasma exchange in methotrexate removal in a patient with osteosarcoma and acute renal insufficiency. Am J Hematol 2003; 72: 209–211
- Djerassi I, . Controversies in Oncology, , et al. Wiley, New York 1982; 325–352
- Pinedo H M, Zaharko D S, Bull J M, et al. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides. Cancer Res 1976; 36: 4418–4424
- Widemann B C, Adamson P C. Understanding and managing methotrexate nephrotoxicity. The Oncologist. 2006; 11: 694–703
- Buchen S, Ngampolo D, Melton R G, et al. Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure. Br J Cancer 2005; 92: 480–487
- Widemann B C, Hetherington M L, Murphy R F, Balis F M, Adamo P C. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephotoxicity. Cancer 1995; 76: 521–526